Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tomas Orozco Insider Profile
4 Followers
Tomas Orozco, EVP, Consumer Care at NeueHealth Inc, holds 5.09K shares in NeueHealth Inc (Ticker: NEUE). Most recently, Tomas Orozco Sold $822 shares of NeueHealth Inc on Mar 20, 2024 for an estimated value of 5.98K.
Tomas Orozco NeueHealth Inc (NEUE)EVP, Consumer Care
NeueHealth Inc (NEUE)
EVP, Consumer Care
Ranked #17,077 out of 100,202 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+46.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
EVP, Consumer Care
Roles that Tomas Orozco holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tomas Orozco
Tomas Orozco's Trading History
List of latest transactions for each holding click on a transaction to see Tomas Orozco's performance on stock
You May Also Like
Tomas Orozco insider profile FAQ
What is the percentage of profitable transactions made by Tomas Orozco?
The percentage of profitable transactions made by Tomas Orozco is 100%.
What is the average return per transaction made by Tomas Orozco?
The average return per transaction made by Tomas Orozco is 46.30%.
What stocks does Tomas Orozco hold?
Tomas Orozco holds: NEUE stocks.
What was Tomas Orozco’s latest transaction?
Tomas Orozco latest transaction was an Informative Sell of $5.98K.
What was Tomas Orozco's most profitable transaction?
Tomas Orozco’s most profitable transaction was an Informative Sell of NEUE stock on March 13, 2024. The return on the trade was 47.70%.
What is Tomas Orozco's role in NeueHealth Inc?
Tomas Orozco's role in NeueHealth Inc is EVP, Consumer Care.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.